Quantification of epimeric budesonide and fluticasone propionate in human plasma by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry
Yn. Li et al., Quantification of epimeric budesonide and fluticasone propionate in human plasma by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry, J CHROMAT B, 761(2), 2001, pp. 177-185
A highly sensitive and selective liquid chromatography-atmospheric pressure
chemical ionization tandem mass spectrometry assay was developed and valid
ated for simultaneous determination of epimeric budesonide (BUD) and flutic
asone propionate (FP) in plasma. The drugs were isolated from human plasma
using C-18 solid-phase extraction cartridges, and epimeric BUD was acetylat
ed with a mixture of 12.5% acetic anhydride and 12.5% triethylamine in acet
onitrile, to form the 21-acetyl derivatives following the solid-phase extra
ction. Deuterium-labelled BUD acetate with an isotopic purity > 99% was syn
thesized and used as the internal standard. The assay was linear over the r
anges 0.05-10.0 ng/ml for epimeric BUD, and 0.02-4.0 ng/ml. for FP. The int
er- and intra-day relative standard deviations were < 14.3% in the assay co
ncentration range. (C) 2001 Elsevier Science B.V. All rights reserved.